130 / 464
130
SCIENTIFIC PROGRAMME
| Programme and Exhibition Guide
MONDAY 8 MAY 2017
09:39 > Can we perform RCTs evaluating MR guided radiotherapy?
Speaker: V. Valentini (Italy)
SP-0396
SYMPOSIUMWITH PROFFERED PAPERS
Novel approaches in head and neck tumour control
08:45 - 10:00 | LEHAR 4
Chair: R. Suwinski (Poland)
Co-chair: A. Schratter-Sehn (Austria)
08:45 > State of the art in head and neck tumour radiobiology
B. O’Sullivan (Canada)
SP-0397
09:12 > Novel developments in the radiobiology of HPV-positive head and neck
tumours
S. Nuyts (Belgium)
SP-0398
09:39 > Transcriptome analyses of the radiation response in HNSCC cells with
different radiation sensitivity
J. Heß (Germany), A. Michna, U. Schötz, M. Selmansberger,
H. Zitzelsberger, K. Unger, K. Lauber
OC-0399
09:49 > Prognostic impact of tumor infiltrating lymphocytes and PD-L1
expression in head and neck cancers
D. Ou (France), J. Adam, I. Garberis, P. Blanchard, F. Nguyen, A. Levy,
O. Casiraghi, P. Gorphe, I. Breuskin, F. Janot, S. Temam, J. Scoazec,
E. Deutsch, Y. Tao
OC-0400
SYMPOSIUM
Experimental therapies
08:45 - 10:00 | STRAUS 2-3
This session deals with two treatment modifiers and a verification technique based
on Cerenkov radiation. This radiation is emitted when particles pass through tissue
exceeding the speed of light and may be used for QA and real time
in vivo
dosimetry.
Gold nanoparticles tend to have selective uptake in tumours and can be used as
photothermal agent or to enhance local delivery of dose. In grid therapy, dose is
spatially modulated. As hypofractionated boost this was effective in small clinical
series. Its big advantage is reduced toxicity, and the main interest has been in bulky
tumours and palliation.
Chair: M. Van Herk (UK)
Co-chair: F. Mahmood (Denmark)
08:45 > Grid therapy: past, present, and future
Speaker: A. Siegbahn (Sweden)
SP-0401